Primary |
Product Used For Unknown Indication |
18.8% |
Septic Shock |
18.8% |
Guillain-barre Syndrome |
12.5% |
Hypotension |
12.5% |
Plasmapheresis |
12.5% |
Coronary Artery Bypass |
6.3% |
Fluid Replacement |
6.3% |
Off Label Use |
6.3% |
Porphyria Acute |
6.3% |
|
Blood Pressure Decreased |
10.0% |
Therapeutic Product Contamination |
10.0% |
Urticaria |
10.0% |
Drug Ineffective |
5.0% |
Headache |
5.0% |
Medication Error |
5.0% |
No Therapeutic Response |
5.0% |
Pancytopenia |
5.0% |
Product Quality Issue |
5.0% |
Sepsis |
5.0% |
Skin Discolouration |
5.0% |
Splenomegaly |
5.0% |
Throat Tightness |
5.0% |
Unresponsive To Stimuli |
5.0% |
Vomiting |
5.0% |
Wheezing |
5.0% |
Wound Haemorrhage |
5.0% |
|
Secondary |
Maternal Exposure Timing Unspecified |
21.6% |
Drug Use For Unknown Indication |
10.8% |
Prevention |
10.8% |
Guillain-barre Syndrome |
8.1% |
Breast Cancer |
6.8% |
Fungal Infection |
5.4% |
Hypertension |
5.4% |
Product Used For Unknown Indication |
4.1% |
Pulmonary Oedema |
4.1% |
Anaemia |
2.7% |
Cholestasis |
2.7% |
Hypothyroidism |
2.7% |
Immunosuppression |
2.7% |
Insomnia |
2.7% |
Vitamin B12 Deficiency |
2.7% |
Anxiety Reaction |
1.4% |
Diabetes Mellitus |
1.4% |
Glomerulonephritis Membranoproliferative |
1.4% |
Nephropathy |
1.4% |
Oedema Lower Limb |
1.4% |
|
Therapeutic Product Contamination |
31.6% |
Pneumonia |
10.5% |
Thrombotic Microangiopathy |
10.5% |
Hepatitis E |
5.3% |
Jaundice |
5.3% |
Liver Disorder |
5.3% |
Organising Pneumonia |
5.3% |
Premature Baby |
5.3% |
Strongyloidiasis |
5.3% |
Tendon Rupture |
5.3% |
Throat Tightness |
5.3% |
Thrombocytopenia |
5.3% |
|
Concomitant |
Product Used For Unknown Indication |
35.0% |
Drug Use For Unknown Indication |
9.5% |
Prophylaxis |
6.4% |
Rectal Cancer |
5.7% |
Gastric Cancer |
4.6% |
Nausea |
4.3% |
Hypertension |
3.7% |
Pain |
3.5% |
Stomatitis |
3.2% |
Vomiting |
3.1% |
Diarrhoea |
3.0% |
Constipation |
2.9% |
International Normalised Ratio Increased |
2.3% |
Premedication |
2.2% |
Hypoalbuminaemia |
2.0% |
Acute Lymphocytic Leukaemia |
1.9% |
Febrile Neutropenia |
1.8% |
Hepatocellular Carcinoma |
1.8% |
Gastrointestinal Haemorrhage |
1.7% |
Insomnia |
1.6% |
|
Pneumonia |
12.4% |
Renal Failure Acute |
11.3% |
Thrombocytopenia |
7.2% |
Renal Failure |
6.2% |
Sepsis |
6.2% |
White Blood Cell Count Decreased |
6.2% |
Non-small Cell Lung Cancer |
5.2% |
Renal Impairment |
5.2% |
Fatigue |
4.1% |
Myocardial Infarction |
4.1% |
Pneumonia Legionella |
4.1% |
Hyperthyroidism |
3.1% |
Rash |
3.1% |
Renal Tubular Acidosis |
3.1% |
Respiratory Failure |
3.1% |
Tachycardia |
3.1% |
Urine Output Decreased |
3.1% |
Ventricular Hypokinesia |
3.1% |
Ventricular Tachycardia |
3.1% |
Vomiting |
3.1% |
|